526 related articles for article (PubMed ID: 28904127)
1. Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection.
Wan SW; Chen PW; Chen CY; Lai YC; Chu YT; Hung CY; Lee H; Wu HF; Chuang YC; Lin J; Chang CP; Wang S; Liu CC; Ho TS; Lin CF; Lee CK; Wu-Hsieh BA; Anderson R; Yeh TM; Lin YS
J Immunol; 2017 Oct; 199(8):2834-2844. PubMed ID: 28904127
[TBL] [Abstract][Full Text] [Related]
2. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.
Wan SW; Lu YT; Huang CH; Lin CF; Anderson R; Liu HS; Yeh TM; Yen YT; Wu-Hsieh BA; Lin YS
PLoS One; 2014; 9(3):e92495. PubMed ID: 24658118
[TBL] [Abstract][Full Text] [Related]
3. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
Kao YS; Yu CY; Huang HJ; Tien SM; Wang WY; Yang M; Anderson R; Yeh TM; Lin YS; Wan SW
J Immunol; 2019 Oct; 203(7):1909-1917. PubMed ID: 31451673
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).
Gelanew T; Poole-Smith BK; Hunsperger E
J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890
[TBL] [Abstract][Full Text] [Related]
5. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
[TBL] [Abstract][Full Text] [Related]
6. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage.
Chao CH; Wu WC; Lai YC; Tsai PJ; Perng GC; Lin YS; Yeh TM
PLoS Pathog; 2019 Apr; 15(4):e1007625. PubMed ID: 31009511
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.
Tien SM; Chang PC; Lai YC; Chuang YC; Tseng CK; Kao YS; Huang HJ; Hsiao YP; Liu YL; Lin HH; Chu CC; Cheng MH; Ho TS; Chang CP; Ko SF; Shen CP; Anderson R; Lin YS; Wan SW; Yeh TM
PLoS Pathog; 2022 Apr; 18(4):e1010469. PubMed ID: 35486576
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).
Gelanew T; Hunsperger E
Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531
[TBL] [Abstract][Full Text] [Related]
9. Serotype-specific anti-Dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production.
Masrinoul P; Omokoko MD; Pambudi S; Ikuta K; Kurosu T
Viral Immunol; 2013 Aug; 26(4):250-8. PubMed ID: 23941673
[TBL] [Abstract][Full Text] [Related]
10. Anti-dengue virus nonstructural protein 1 antibodies contribute to platelet phagocytosis by macrophages.
Wan SW; Yang YW; Chu YT; Lin CF; Chang CP; Yeh TM; Anderson R; Lin YS
Thromb Haemost; 2016 Mar; 115(3):646-56. PubMed ID: 26632672
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency.
Chen MC; Lin CF; Lei HY; Lin SC; Liu HS; Yeh TM; Anderson R; Lin YS
J Immunol; 2009 Aug; 183(3):1797-803. PubMed ID: 19592650
[TBL] [Abstract][Full Text] [Related]
12. Anti-dengue virus nonstructural protein 1 antibodies cause NO-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3β and NF-κB activation.
Chen CL; Lin CF; Wan SW; Wei LS; Chen MC; Yeh TM; Liu HS; Anderson R; Lin YS
J Immunol; 2013 Aug; 191(4):1744-52. PubMed ID: 23851680
[TBL] [Abstract][Full Text] [Related]
13. A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients.
Omokoko MD; Pambudi S; Phanthanawiboon S; Masrinoul P; Setthapramote C; Sasaki T; Kuhara M; Ramasoota P; Yamashita A; Hirai I; Ikuta K; Kurosu T
Am J Trop Med Hyg; 2014 Jul; 91(1):146-55. PubMed ID: 24778195
[TBL] [Abstract][Full Text] [Related]
14. Dengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation.
Chuang YC; Lin J; Lin YS; Wang S; Yeh TM
J Immunol; 2016 Feb; 196(3):1218-26. PubMed ID: 26712948
[TBL] [Abstract][Full Text] [Related]
15. A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
Huang HJ; Yang M; Chen HW; Wang S; Chang CP; Ho TS; Kao YS; Tien SM; Lin HH; Chang PC; Lai YC; Hsiao YP; Liu YL; Chao CH; Anderson R; Yeh TM; Lin YS; Wan SW
Vaccine; 2022 Apr; 40(15):2299-2310. PubMed ID: 35287985
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
[TBL] [Abstract][Full Text] [Related]
17. Avian anti-NS1 IgY antibodies neutralize dengue virus infection and protect against lethal dengue virus challenge.
O'Donnell KL; Espinosa DA; Puerta-Guardo H; Biering SB; Warnes CM; Schiltz J; Nilles ML; Li J; Harris E; Bradley DS
Antiviral Res; 2020 Nov; 183():104923. PubMed ID: 32979401
[TBL] [Abstract][Full Text] [Related]
18. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis.
Falconar AK
Arch Virol; 1997; 142(5):897-916. PubMed ID: 9191856
[TBL] [Abstract][Full Text] [Related]
19. Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection.
Lai YC; Chuang YC; Liu CC; Ho TS; Lin YS; Anderson R; Yeh TM
Sci Rep; 2017 Aug; 7(1):6975. PubMed ID: 28765561
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines.
Falconar AK
Clin Vaccine Immunol; 2008 Mar; 15(3):549-61. PubMed ID: 18160621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
